Icon forms partnership with University College Dublin

Wednesday, September 5, 2012 10:13 AM

Icon, a global provider of outsourced development services, has entered into a strategic partnership with University College Dublin (UCD), Ireland’s largest third-level institution.

The partnership supports a shared vision for transforming research, teaching, training and innovation in the sciences in Ireland and aims to strengthen the ties between academic research and industry.

As part of the partnership Icon has established the Icon Newman Fellowship in Genomics, a two-year post-doctoral fellowship based in the UCD School of Medicine and Medical Science and the UCD Complex and Adaptive Systems Laboratory (CASL). The first recipient of the Icon Newman Fellowship in Genomics is Colm J. Ryan. Originally a software developer, Colm carried out a PhD in bioinformatics and will now conduct research into the control of gene expression by inherited variants, focusing on cardiovascular diseases and cancer.

Icon will also become a lead benefactor of the new UCD Science Centre, a 67,000 square meter building which will be home to Ireland’s largest science community. Icon and UCD will also collaborate to explore ways of enhancing drug development which has the potential to include tailored teaching programs and internships in clinical research that will be available in Ireland and internationally through some of UCD’s university partners.

“It is important that we continue to develop our scientific capabilities and build a pool of talent that can support our growth plans,” said Ciaran Murray, CEO of Icon. “Bridging the ties between industry and academic research through our partnership with UCD supports both of these objectives. UCD is at the leading edge of scientific knowledge and discovery in Ireland and shares Icon’s commitment to innovation. The partnership is built on creating an environment that will inspire future generations to engage in science, supporting Ireland’s efforts to develop as an important centre for research and development.”   

Dr. Hugh Brady, president of UCD, said, “This strategic partnership with Icon is a model for industry-academia collaborations. The commitment by Icon to invest in both capital infrastructure and young research talent demonstrates their visionary leadership and places Icon in that exceptional group of leaders who appreciate that world-class facilities are fundamental for Irish universities to compete globally.” He added, “Partnerships such as this are an example of how industry and academia can combine their expertise in support of the national economic agenda.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs